RWM
TMO icon

Rockline Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Rockline Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,669
Closed -$830K – 104
2025
Q1 		$830K Buy
1,669
+140
+9% +$75.8K 0.23% 57
2024
Q4 		$795K Buy
1,529
+85
+6% +$46.7K 0.21% 63
2024
Q3 		$893K Buy
1,444
+115
+9% +$68.1K 0.25% 62
2024
Q2 		$735K Buy
1,329
+30
+2% +$17.2K 0.23% 62
2024
Q1 		$755K Buy
1,299
+108
+9% +$60.6K 0.26% 63
2023
Q4 		$632K Buy
+1,191
New +$576K 0.26% 66

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rockline Wealth Management's TMO Position: Q2 2025 in Review

Rockline Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 1,669 shares — an estimated $830K sold.

Rockline Wealth Management first reported a position in TMO in Q4 2023 and held it in 6 quarters. The position peaked at $893K in Q3 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Rockline Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Rockline Wealth Management sold 1,669 Thermo Fisher Scientific shares in Q2 2025, an estimated $830K.
  • Rockline Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 6 quarters.
  • Rockline Wealth Management's Thermo Fisher Scientific position peaked at $893K in Q3 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Rockline Wealth Management's 13F filing for Q2 2025, filed 5 Aug 2025.